AmpCβ-乳糖酶的纳米抑制剂
Federica Morandi1, Emilia Caselli, Stefania Morandi
1Department of Pharmaceutical Chemistry, University of California, San Francisco, Mission Bay Genentech Hall, 600 16th Street, Mail Box 2240, 94143, USA.
Journal of the American Chemical Society
|January 16, 2003
概括
新的甘酸抑制剂对抗β-乳酸酶耐药性. 这些化合物具有很高的亲和力和选择性,可以逆转细菌对抗生素的耐药性,例如ceftazidime.
科学领域:
- 药用化学 医学化学
- 生物化学 生物化学
- 结构生物学 结构生物学
背景情况:
- β-乳糖酶是细菌对β-乳糖抗生素耐药的主要机制.
- C类β-乳糖酶AmpC是打击抗生素耐药性的重要目标.
研究的目的:
- 设计和评估针对AmpC.的新型碳基基酸过渡状态模拟抑制剂.
- 了解有助于抑制剂结合和亲缘关系的分子相互作用.
主要方法:
- 使用立体选择性有机合成来制造新的抑制化合物.
- 酶学,微生物学和X射线晶体学被用来评估抑制剂的疗效和结构.
主要成果:
- 与现有类似物相比,新的抑制剂显示出明显改善的抑制 (超过2个数量级),K (i) 值低至1nM.
- X射线结晶学揭示了这些抑制剂的高亲和力的结构基础.
- 最高亲和度的抑制剂逆转了临床病原体的塞夫塔齐迪姆耐药性,并且对血清蛋白酶具有很高的选择性.
结论:
- 炭基基酸是AmpC的强有力的过渡状态模拟抑制剂.
- 碳酸盐组在C类β-乳酸酶的分子识别中起着至关重要的作用.
- 这些发现为开发新药的基础,以克服细菌对β-乳糖抗生素的耐药性.
相关概念视频
Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...


